Long-Term Outcome of Spinal Cord Stimulation for Chronic Pain Management

Author(s):  
Giancarlo Barolat ◽  
Beth Ketcik ◽  
Jiping He
2004 ◽  
Vol 15 (02/03) ◽  
pp. 151-175 ◽  
Author(s):  
Giancarlo Barolat ◽  
Ashwini Sharan

2020 ◽  
Vol 192 (42) ◽  
pp. E1264-E1267
Author(s):  
Aaron Hong ◽  
Vishal Varshney ◽  
Gregory M.T. Hare ◽  
C. David Mazer

2019 ◽  
Vol 23 (6) ◽  
Author(s):  
Omar Viswanath ◽  
Ivan Urits ◽  
Emily Bouley ◽  
Jacquelin M. Peck ◽  
William Thompson ◽  
...  

Neurosurgery ◽  
2018 ◽  
Vol 84 (5) ◽  
pp. 1011-1018 ◽  
Author(s):  
Mette Nissen ◽  
Tiina-Mari Ikäheimo ◽  
Jukka Huttunen ◽  
Ville Leinonen ◽  
Mikael von und zu Fraunberg

Abstract BACKGROUND Failed back surgery syndrome (FBSS) is a challenging condition that lacks a curative treatment. In selected patients, spinal cord stimulation (SCS) has provided a satisfactory outcome. OBJECTIVE To evaluate the long-term outcome of SCS in FBSS, as measured by (1) the explantation rate, (2) complications, and (3) patient satisfaction with the global perceived effect (GPE). METHODS We studied 224 consecutive FBSS patients who underwent an SCS trial with surgically implanted leads at our hospital between January 1996 and December 2014. The patients’ satisfaction with the GPE of treatment was measured through a postal questionnaire at the end of follow-up. RESULTS Based on a 1-wk trial, permanent SCS was implanted in 175 (78%) patients. Out of these patients, 153 (87%) reported satisfactory outcomes after 2 mo. During the mean follow-up of 6 yr, 34 (19%) of SCS devices were permanently explanted due to inadequate pain relief, and 11 (6%) were explanted for other reasons. Electrode revision due to inadequate pain relief was done for 22 patients. In total, 26 complications were reported due to: 7 deep infections, 11 hardware malfunctions, 1 subcutaneous hematoma, 4 instances of discomfort due to the pulse generator, and 3 electrode migrations. One hundred thirty patients (74%) continued with SCS until the end of follow-up. Of them, 61 (47%) returned the questionnaire, and 42 (69%) reported substantially improved or better GPE. CONCLUSION SCS can provide a good outcome in the treatment of FBSS. Patient selection could be further improved by developing novel predictive biomarkers.


Author(s):  
V Varshney ◽  
R Sahjpaul ◽  
J Osborn

Background: The challenges of chronic pain management, and resulting poorer outcomes, in workers’ compensation (WCB) patients has been well established. Spinal cord stimulation (SCS) has been used for the management of low back and radicular neuropathic pain with varying effectiveness and it’s efficacy in the WCB population has been challenged. We sought to examine our experience using SCS in WCB compared to non WCB patients. Methods: A retrospective analysis of 71 WCB patients assessed and treated at the St Pauls Hospital neuromodulation program between 2016-2021 was performed. This group was compared to a cohort on non WCB patients in terms of the likelhood of being offered a trial, proceeding with trial if offered, and the likelhood of a successful trial proceeding to implant. Results: Compared to non WCB, the WCB patients were more likely to be offered a trial (86% vs 77%) and more likely to proceed with a trial if offered (82% vs 71%). Trial to implant ratios were similar in both WCB and non WCB patients (78% vs 77%). Conclusions: WCB patients were more likely to be offered a SCS trial and more likely to accept if offered, compared to non-WCB patients. However, both groups were similar in trial to implant probability.


Pain Practice ◽  
2004 ◽  
Vol 4 (3) ◽  
pp. 204-221 ◽  
Author(s):  
Diego Beltrutti ◽  
Aldo Lamberto ◽  
Giancarlo Barolat ◽  
Stephen P. Bruehl ◽  
Daniel Doleys ◽  
...  

2008 ◽  
Vol 12 (1) ◽  
pp. 132-136 ◽  
Author(s):  
Göran Lind ◽  
Gastón Schechtmann ◽  
Jaleh Winter ◽  
Björn A. Meyerson ◽  
Bengt Linderoth

Sign in / Sign up

Export Citation Format

Share Document